Cleveland BioLabs taps BioProcess Capital's Kasimova for board

Biopharmaceutical company Cleveland BioLabs Inc has appointed Elena Kasimova to its board of directors. Kasimova is a director of strategy and investment at BioProcess Capital Partners.

28 January 2015•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles